SEC
SlamSEC
SearchBrowseEarnings

Zivo Bioscience, Inc.

OTC:ZIVOOTC:ZIVOW
Biological Products, (No Diagnostic Substances)·BLOOMFIELD HILLS, MI
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Revenue
$27,650
FY 2024
Adj. EBITDA
-$7.2M
-25937.0% margin
FY 2024
Net Income
-$7.8M
-28127.2% margin
FY 2024
EPS (Diluted)
-$4.60
FY 2024
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$137,862
FY 2022
Total Debt
$121,700
FY 2021
Net Cash
$16,162
FY 2021
Enterprise Value
—
Debt / EBITDA
0.0x
FY 2024
EV / EBITDA
—
Employees
—